Skip to main content
Equibles

CITIGROUP INC

Position in COLL — Collegium Pharmaceutical, Inc

CIK 831001 NEW YORK, NY
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,581,107
-$119,054 QoQ
Shares Held
43,677
-15.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. COLL ranks #22 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 262,200 $142,067,824
2 ZTS
Zoetis Inc.
 1,265,210 $90,917,989
3 TEVA
Teva Pharmaceutical Industries Ltd
 2,527,031 $85,615,809
4 VTRS
Viatris Inc
 4,360,444 $69,243,850
5 NBIX
Neurocrine Biosciences Inc
 179,076 $30,181,467
6 INDV
Indivior Pharmaceuticals, Inc.
 643,006 $26,382,535
7 LNTH
Lantheus Holdings, Inc.
 189,692 $21,044,429
8 HLN
Haleon plc
 1,507,538 $14,065,329

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,581,107 43,677
2026-03-31 $1,700,161 51,411
2025-12-31 $2,726,838 58,895
2025-09-30 $3,029,748 86,589
2025-06-30 $3,187,556 107,797
2025-03-31 $1,615,003 54,104
2024-12-31 $1,533,376 53,521
2024-09-30 $1,934,703 50,070
2024-06-30 $1,025,698 31,854
2024-03-31 $1,983,817 51,103
2023-12-31 $783,287 25,448
2023-09-30 $370,450 16,575
2023-06-30 $713,402 33,197
2023-03-31 $457,463 19,069
2022-12-31 $518,241 22,338
2022-09-30 $458,988 28,651
2022-06-30 $487,760 27,526
2022-03-31 $883,237 43,381
2021-12-31 $730,182 39,089
2021-09-30 $612,907 31,049
2021-06-30 $594,475 25,147
2021-03-31 $514,810 21,722
2020-12-31 $223,634 11,165
2020-09-30 $197,269 9,475
2020-06-30 $764,225 43,670
2020-03-31 $202,621 12,408